Jennifer A Kearney

Immunochem Therapeutics, LLC

NIH Rank #4795
  • Program Leader
  • R01 Holder
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$2.1M
Fiscal year 2024
Grants Awarded
4
Active NIH grants
National Rank
#4,795
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2.1M across 4 grants · National rank #4795.

Top grants by award amount

Jennifer A Kearney's NIH grant portfolio, ranked by award amount.

  • 4R44AG071062-02R44
    Development of a novel anti-neuroinflammatory experimental therapeutic for epilepsy and Alzheimer's risk
    $1.2M
    award amount
  • 5R01NS084959-10R01
    Genetic Modifiers of Childhood Epilepsy
    $472K
    award amount
  • 1P50MH132775-01A1P50
    Control of synaptic circuits by small GTPase pathways
    $209.7K
    award amount
  • 5R21NS134236-02R21
    Genetic Mapping of Modifier Loci in a Mouse Model KCNB1 Encephalopathy
    $200K
    award amount

Affiliations

Institutions that have administered grants for Jennifer A Kearney.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Immunochem Therapeutics, LLC
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #4795
  6. 2024
    Entered Top 25% Nationally
    Ranked #4795
  7. 2024
    Multi-Institutional Research
    Awards at 2 institutions

Related investigators

Other NIH-funded PIs frequently associated with Jennifer A Kearney.